3 reasons Emergence companies should apply for the BioInnovation Challenge

July 26, 2021

Now in its eleventh year, the BioInnovation Challenge (BIC) is a pitching competition for early-stage life sciences companies in Atlantic Canada. BIC was created by BioNova to help ease the transition from research to market and recognize the significant commercialization potential of the bioscience sector in Atlantic Canada.

Last year, Emergence client Swiftsure Innovation was the winner of the BIC, and AffinityImmuno was a semi-finalist. This year’s finalists will present at BioPort 2021 in November.

Here are three reasons you should consider applying:

Access to funding
The winner of the pitch competition will be awarded $25,000 in funding to help develop their business and a $30,000 advisory services package. Since its inception in 2011, BIC has provided more than $465K in grand prize package value to accelerate start-ups.

Pitch training and business development
BIC participants receive pitching and business training to help position their company for continued growth. BIC also connects finalists with investors, the media and industry influencers. Take advantage of the spotlight and kick-start your success.

Applying is easy
Full application is available on the BioPort website. Deadline for applications is Friday, August 6, 2021. Email kmannette@bionova.ca for questions and for more information.

Emergence is a proud supporter of BIC. For more information on the program, visit their website.